Issue 4
-
Opioid crisis could offer opportunity for pain management research
APR Distinguished Lecturer Charles G. Helmick III, MD, provided a look a public health and why it’s important — and why arthritis and other rheumatologic conditions are public health issues.
-
Treatment of scleroderma involves multifaceted approach
Three scleroderma experts will outline approaches to scleroderma skin involvement, interstitial lung disease, and pulmonary hypertension during the Wednesday Clinical Practice session, Scleroderma Treatment 2019.
-
Harness RISE registry’s capabilities to improve practice, research
The registry is a rich, best-in-class resource developed by the American College of Rheumatology, and is the first and largest national EHR-enabled rheumatology registry in the United States.
-
Researchers’ understanding of complement’s role in inflammatory disease continues to evolve
New findings open up the potential for new therapies for autoimmune and inflammatory diseases, such as RA, that target these new functions of complement.
-
Breakthroughs in histiocytic diseases leading to new treatments
Tuesday will see the ACR’s first-ever session on histiocytic disorders, which have traditionally been seen as rare, obscure, and without good treatment options.
-
ACR Board of Directors meet at the Annual Meeting
On Saturday, the ACR Board of Directors met to discuss current and future initiatives that impact the ACR’s diverse membership and advance rheumatology.